RNV ASX · Health Care

Renerve Ltd

Announcements, last 12 months: 91
Price sensitive, last 12 months: 28
Followed on InvestorPA: Low (Outside the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
19 Oct 2026, 9:20 AM	Positive 12-Month Data for NervAlign Nerve Guide Matrix Price sensitive	AI summary
14 Oct 2026, 9:28 AM	Positive FDA Feedback on NervAlign Nerve Guide Matrix Price sensitive	AI summary
6 Oct 2026, 1:34 PM	Change of Director's Interest Notice - P Savage
6 Oct 2026, 1:34 PM	Change of Director's Interest Notice - M McGuire
6 Oct 2026, 1:33 PM	Change of Director's Interest Notice - J Chick
6 Oct 2026, 1:18 PM	Cleansing Notice
6 Oct 2026, 1:14 PM	Application for quotation of securities - RNV
6 Oct 2026, 9:53 AM	Proposed issue of securities - RNV
6 Oct 2026, 9:50 AM	Notification regarding unquoted securities - RNV
5 Oct 2026, 3:11 PM	Results of Meeting

Sign in to see all RNV announcements.

Guidance history

5 Oct 2026	Annual revenue up 88%, $5M funding facility with Riverfort, Q2 2026
21 Sep 2026	FY26 sales of $510,357, up 88% on the prior year
19 Aug 2026	Annual revenue up 88%, Q4 revenue up 50%, cash position $1.48M, $5M funding facility

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow RNV to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.